Cargando…
Differential proteomic alterations between localised and metastatic prostate cancer
Molecular alterations in the prostate cancer proteome mediate the functional and phenotypic transformation from clinically localised to metastatic cancer, a transition that drives patient's mortality and challenges therapeutic intervention. A first approximation of differential proteomic altera...
Autores principales: | Taylor, B S, Varambally, S, Chinnaiyan, A M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360675/ https://www.ncbi.nlm.nih.gov/pubmed/16880794 http://dx.doi.org/10.1038/sj.bjc.6603274 |
Ejemplares similares
-
Proton beam therapy and localised prostate cancer: current status and
controversies
por: Efstathiou, J A, et al.
Publicado: (2013) -
Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments
por: Payne, H, et al.
Publicado: (2011) -
Noncoding RNA localisation mechanisms in chromatin regulation
por: Kanhere, Aditi, et al.
Publicado: (2012) -
Imaging metastatic bone disease from carcinoma of the prostate
por: Messiou, C, et al.
Publicado: (2009) -
Quick microbial molecular phenotyping by differential shotgun proteomics
por: Gouveia, Duarte, et al.
Publicado: (2020)